The video features leading experts discussing the latest advancements and challenges in treating multiple myeloma, focusing on therapies like CAR-T cells and bispecific antibodies. They highlight strategies for managing side effects, particularly infection risks and cardiotoxicity, emphasizing patient education and proactive management. The conversation also explores the potential of new drug combinations and personalized treatment approaches to balance efficacy with quality of life.

Date of original release: 30 October 2024

Date credits expire: 30 October 2025

This webinar has been supported by an independent educational grant from Janssen Pharmaceuticals. Janssen Pharmaceuticals has had no influence over the content or selection of the Editorial Panel.